Topical Oxygen being trialled for sun damaged skin

Written by on October 8, 2009 in clinical trials with 0 Comments

A trial seeking participants interested in being treated with topically disolved oxygen (TDO) has been posted to Aria Aesthetics is listed as supplying the `Aria Regimens’ in 0.5%, and 0.25%. As the trial is double blind and placebo controlled, a third group will receive no TDO during their treatments.

Zoe Draelos MD is listed as a contact for the trial. Dr. Draelos is well known to rosacea sufferers. You can read some more of her research via the popular Rosacea News items: cleansing and the management of rosacea, finacea is good for acne and hyper pigmentation as well, and cetaphil gentle skin cleanser well tolerated.

Not a lot can be found on the internet about the company or the product mentioned in this trial. It seems that Topical Dissolved Oxygen has been trialled as a wound healing stimulant – an alternative to hyperbaric chamber therapy. If you have any more information, please post in the comments below.

The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage

This study is an evaluation of the role of topical dissolved oxygen to lessen visible signs of photodamage using a select regimen of topical dissolved oxygen containing cosmeceutical products. Evaluation of the overall skin tolerability of topical dissolved oxygen (safety) utilizing the regimen of products.

Related Items

Read more about: clinical trials

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed

Leave your comment here


Discover more from Rosacea Support Group

Subscribe now to keep reading and get access to the full archive.

Continue reading

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.